ReviewMolecular biology reports2025
Brown adipocytes from pluripotent stem cells: a promising therapy for obesity.
Review in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The identification of functional brown adipose tissue (BAT) and beige adipose tissue with significant thermogenic capabilities in adults has opened new avenues in the battle against obesity and its associated comorbidities.However, although obesity can be alleviated through strategies such as increasing physical activity, improving diet, and drug intervention, these methods all have inherent limitations, such as low compliance and obvious side effects. Consequently, there is an urgent need to investigate novel and effective methods for combating obesity. With ongoing advancements in stem cell technology, stem cell therapy has emerged as a promising strategy. Recent studies have demonstrated that certain pluripotent stem cells can differentiate into BAT under specific conditions and, when transplanted into mice, can elevate the animals' body temperature and metabolic rate. This suggests that pluripotent stem cells may represent a viable therapeutic option for addressing metabolic disorders such as obesity and diabetes. Owing to their distinct advantages, pluripotent stem cells have become the preferred choice for stem cell therapy in the treatment of obesity. This article will mainly focus on the differentiation process of pluripotent stem cells into brown adipocytes, as well as the application of gene editing technology in this field.
Indexed as
Identifiers
41264146What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.